非人灵长类个性化麻醉方案的探讨

目的 比较氯胺酮、舒泰、速眠新Ⅱ、戊巴比妥钠等4种全身麻醉药或其组合对非人灵长类的麻醉效果,探寻能替代或者减少氯胺酮使用的个性化麻醉方案。方法 以单独使用氯胺酮麻醉的方案作为对照,另设单独使用舒泰、氯胺酮复合速眠新Ⅱ、舒泰复合速眠新Ⅱ和戊巴比妥钠复合速眠新Ⅱ等麻醉4个实验组,每组选取5只食蟹猴进行实验,记录麻醉后的心率、体温、血氧饱和度、以及麻醉诱导时间和维持时间,以比较各方案的麻醉效果。结果 与单独使用氯胺酮麻醉比较,其他四种麻醉方案在心率、体温、血氧饱和度和麻醉诱导时间上均无显著性差异,不同方案麻醉维持时间分布在30~200min之间。在非人灵长类的全身麻醉中,舒泰可以很好地替代氯胺酮;氯胺酮复合速眠新Ⅱ麻醉可取得较长的麻醉维持时间,并减少氯胺酮的使用量;舒泰与速眠新Ⅱ联用、戊巴比妥钠与速眠新Ⅱ联用的方案也可替代氯胺酮,且麻醉维持时间较长。结论 在一定的麻醉时间内,联合用药可以降低氯胺酮的使用量,不同麻醉方案灵活运用可满足不同实验对麻醉维持时间的需求。     

速眠新与盐酸氯胺酮对猕猴麻醉效果的初步观察

目的　比较速眠新与盐酸氯胺酮和速眠新复合麻醉对猕猴的麻醉效果。方法　成年健康猕猴 10只 ,动物分成单纯麻醉组 (速眠新组 ,5只 )和复合麻醉组 (速眠新和盐酸氯胺酮组 ,5只 ) ,均采用肌内注射麻醉。结果　速眠新麻醉维持时间仅 0～ 1h ,麻醉效果低于复合麻醉效果。速眠新有较好的镇静、镇痛和肌肉松弛作用 ,复合麻醉使速眠新效果更佳 ,麻醉时间更长、更稳定 (1～ 2h) ,复苏期较快。结论　速眠新和盐酸氯胺酮复合麻醉适合动物实验时间较长的手术 ,是一种较理想的实验动物麻醉方法     

四种常用实验麻醉药物对大鼠心血管系统的影响

目的探讨不同动物实验麻醉药物对大鼠心血管系统的影响。方法采用Bio Pac MP150动态记录四种麻醉药物麻醉后大鼠的心电图、血压,采集麻醉后不同时间点大鼠的血糖以及实验终点肝肾功能、心肌酶、电解质。结果水合氯醛可引起严重的室性心律失常,异氟烷对心率有抑制作用,戊巴比妥钠可引起大鼠心电图P波增高,乌拉坦可引起大鼠心电图J点抬高。乌拉坦、戊巴比妥钠均可引起SBP升高,水合氯醛可引CK升高,异氟烷可降低CK、CKMB,戊巴比妥钠、异氟烷有降低ALT、AST的作用,水合氯醛、戊巴比妥钠、异氟烷均可降低肌酐,四种麻醉药物均有降低血钠、血钾的作用。结论水合氯醛对心血管系统的影响明显,不适合用于心血管病的动物实验研究,戊巴比妥钠、乌拉坦、异氟烷可适当选择作为心血管病的动物实验研究。     

三种麻醉方法在骨科动物实验中效果比较

目的比较3种麻醉方法在骨科动物实验中的效果,从而得出最佳方法。方法将80只实验动物随机分为3组,A组（速眠新II肌肉注射组）,B组（0.6%戊巴比妥钠静脉注射组）,C组（速眠新II肌肉注射＋0.6%戊巴比妥钠静脉注射联合用药组）,在骨科动物实验中分别进行麻醉、手术,比较3组的麻醉效果,观察其诱导期、麻醉期（麻醉维持时间）、苏醒期、麻醉效果、死亡率等。结果 A组麻醉的诱导期长,效果不好;B组麻醉的诱导期短,但麻醉效果不理想,死亡率高;C组麻醉的诱导期短,麻醉效果好,安全。结论 C组诱导期短,麻醉效果好,安全。无论在实验动物的伦理道德方面,还是在保证动物实验质量方面都是最佳选择。     

不同麻醉方法对大鼠血气电解质及能量代谢的影响

目的探讨不同麻醉方法和不同麻醉药物对大鼠血气、电解质及能量代谢的影响。方法采用异氟烷、乙醚吸入麻醉,戊巴比妥钠、水合氯醛腹腔注射麻醉,经腹主静脉取血,经血气一电解质分析仪全自动分析测定,观察不同麻醉方法和麻醉药物对大鼠血气、电解质及能量代谢的影响。结果异氟烷吸人麻醉组Na’离子浓度略低于戊巴比妥钠腹腔注射组（P〈0．05）;戊巴比妥钠腹腔注射组Ca2离子浓度显著低于其他三组（P〈0．01）;吸入麻醉组的Mg2离子浓度显著高于药物腹腔注射麻醉组（P〈O．05,P〈0．01）;水合氯醛腹腔注射组Lac含量显著高于乙醚和戊巴比妥钠麻醉组（P〈0．01）;吸人类麻醉药能较好的维持较高的PO2、SO2、O2Ct和A（肺泡气中氧分压）,而BE-ECF、BE-B、PCO2、HC03-和TCO2降低,表明不同麻醉药均有不能程度的引起大鼠静脉血血气、电解质及能量代谢产物的改变。结论不同麻醉药物均有不同程度的引起大鼠静脉血血气、电解质及能量代谢产物的改变,异氟烷和乙醚对动物机体心血管、神经系统具有一定的保护作用,机体损害较少,而戊巴比妥钠腹腔注射对动物机体心血管、神经系统具有一定的抑制作用,机体损害较大。因此,在使用麻醉药时应合理选用和控制,避免由于麻醉引起实验误差。     

戊巴比妥钠联用速眠新Ⅱ对西藏小型猪麻醉效果观察

目的观察联合应用速眠新Ⅱ和戊巴比妥钠对西藏小型猪的麻醉效果。方法采用速眠新Ⅱ（0.1mL/kg）肌内注射和3%戊巴比妥钠生理盐水溶液（0.2 mL/kg）静脉注射联合麻醉方法对15头行胚胎移植术的西藏小型猪进行麻醉,观察动物麻醉维持时间、镇痛效果、呼吸频率和心率变化及术后苏醒情况。结果80%（12头/15头）西藏小型猪初始量麻醉状态维持45 min以上,20%（3头/15头）西藏小型猪手术过程中追加麻醉。麻醉期间肌肉松弛效果好,动物呼吸和心率平稳。手术过程中西藏小型猪呼吸频率为（12-22）次/min,心率为（63-85）次/min,麻醉过程中未出现麻醉死亡,术后苏醒时间为30-60 min。结论速眠新和戊巴比妥钠混合麻醉效果好,且麻醉剂量较以往大幅减少,术后苏醒快。戊巴比妥钠联用速眠新复合麻醉对西藏小型猪是一种较理想的麻醉方法,且动物麻醉安全性高。     

眠乃宁对金钱豹麻醉效果的观察

眠乃宁是一种在梅花鹿、马鹿和熊等草食、杂食野生动物上使用比较广泛的麻醉药。为了探索眠乃宁对金钱豹的麻醉效果,进行了眠乃宁对金钱豹的麻醉试验。通过眠乃宁对金钱豹麻醉效果的观察和分析,表明眠乃宁具有较好的镇静、镇痛和肌肉松驰作用,其副作用小,效果确实、安全,适合用于金钱豹转移、采血、检查、治疗、手术等时的麻醉。     

食蟹猴经股静脉导管长期给药方法的建立

目的建立一种可靠的食蟹猴经股静脉导管长期给药的方法.方法选取20只雄性食蟹猴,麻醉后经股静脉造口,插入静脉导管,将植入式通道与导管连接并将其埋植于背部皮下,通过与植入式通道相连的输液泵进行给药.分别于术前1周、术后1周及术后2周测定血常规、血凝、生化等值.结果全部动物都能完成为期3个月的给药,手术感染率、导管堵塞率较低,分别为10%和5%.术后两周89.5%的生理指标与术前相比,差异无统计学意义(P>0.05).结论该实验采用的食蟹猴经股静脉插管并通过输液泵进行长期给药是一种安全、有效的方法,可广泛用于药理学及毒理学实验.     

雄性食蟹猴高敏C反应蛋白基础值及高脂膳食诱导后与血脂变化的关系研究”

本研究针对不同年龄段和高脂膳食诱导后雄性食蟹猴的高敏C反应蛋白(hs-CRP)的变化规律进行了研究。实验利用免疫比浊法对不同年龄段食蟹猴的后肢静脉血测定,并选择中年雄性食蟹猴饲喂高脂饲料,研究高脂膳食条件下hs-CRP值的变化及与总胆固醇的关系。结果显示老龄雄性食蟹猴的hs-CRP平均值高于中年和低龄食蟹猴(6.09 mg·L-1±2.06 mg·L-1VS.2.78 mg·L-1±1.48 mg·L-1&2.31 mg·L-1±1.52 mg·L-1),且差异均有统计学意义(P<0.05);老年雄性食蟹猴的hs-CRP值高于雄性群体均值(6.09±2.06 VS.3.19±2.16),差异也有统计学意义(P<0.05)。高脂膳食诱导后,食蟹猴总胆固醇(TC)含量显著升高(P<0.05),hs-CRP与对照组比较也有明显升高(P<0.05),提示hs-CRP可能与高脂含量有一定相关性,在心血管病动物实验研究中可作为辅助的预警指标。本研究确定了不同年龄段雄性食蟹猴的hs-CRP均值,且不同年龄段间hs-CRP存在差异;雄性食蟹猴经高脂膳食诱导后在总胆固醇含量升高的同时伴随hs-CRP水平的升高。本研究结果可为以灵长类动物为实验动物的心血管病相关研究提供基础数据。     

猪创伤皮肤缺损修复实验中的麻醉研究

目的探索一种适合猪创伤皮肤缺损修复实验的麻醉方法。方法实验分两部分,一是创伤皮肤缺损和修复动物模型制作手术中的麻醉,将14只仔猪随机分为3组,分别采用气管插管呼吸机辅助呼吸氯胺酮、安定、芬太尼复合麻醉、氯胺酮肌注加水合氯醛静滴麻醉、氯胺酮加戊巴比妥钠腹腔注射麻醉。二是换药中的麻醉,将64次麻醉分为3组,分别采用单纯氯胺酮麻醉、单纯戊巴比妥钠腹腔、氯胺酮加戊巴比妥组肌注。观察显效时间、维持时间、呼吸频率、心跳频牢、麻醉效果。结果皮肤创伤缺损和修复动物模型制作手术中,3组麻醉比较结果显示气管插管呼吸机辅助呼吸氯胺酮、安定、芬太尼复合麻醉显效时间快,维持时间可以控制,麻醉效果最好,安全可靠。在换药的麻醉中,氯胺酮加戊巴比显组肌注显效时间比较快,麻醉时间较短,效果好,动物容易苏醒。结论创伤皮肤缺损和修复动物模型制作手术中,采用气管插管呼吸机辅助呼吸氯胺酮、安定、芬太尼复合麻醉是有效安全的麻醉方法;在换药的麻醉中,氯胺酮加戊巴比妥组肌注是较好的麻醉方法。     

Failure of yohimbine to reverse ketamine anesthesia in rhesus monkeys

Yohimbine hydrochloride has been used experimentally to reverse the anesthetic effects of ketamine and xylazine in dogs, cats, cattle and mule deer, but there are no reports of its use in nonhuman primates. Nine adult female rhesus monkeys were given an intravenous dose of either 0.5 mg/kg yohimbine hydrochloride or saline 10 minutes after intramuscular administration of 10 mg/kg ketamine hydrochloride. There was no difference in the duration of anesthesia between the yohimbine and saline treatments, suggesting yohimbine is not effective in the rhesus monkey.     

Hematological and serum biochemical values in cynomolgus monkeys anesthetized with ketamine hydrochloride

The effects of ketamine anesthesia on both hematological and serum biochemical variables were investigated in 19 male and 15 female cynomolgus monkeys. Blood samples were obtained from the cephalic vein within 30 minutes of an intramuscular injection of ketamine hydrochloride (10 mg/kg). Ketamine anesthesia caused a reduction in leukocyte counts and a significant reduction in lymphocytes percentages. Ketamine anesthesia also increased the serum activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and creatine phosphokinase (CPK), but reduced the serum concentrations of glucose, inorganic phosphate, sodium and potassium. The alterations of hematological and serum biochemical values will be discussed. These alterations should be considered when designing studies for and interpreting data from cynomolgus monkeys.     

Effects of single and multiple injections of ketamine hydrochloride on serum hormone concentrations in male cynomolgus monkeys

Using simulated short- and long-term effect studies, we evaluated the effect of ketamine anesthesia on serum cortisol, testosterone, and immunoreactive luteinizing hormone (ILH) and bioactive LH (BioLH) concentrations in adult male cynomolgus monkeys. Cortisol, testosterone, and ILH were measured by use of radioimmunoassay, and BioLH was measured by use of a radioreceptor assay method. For the acute effect, the first group (eight monkeys) was given four successive intramuscular injections of ketamine (10, 5, 5, and 5 mg/kg of body weight at 0, 30, 60, and 110 min respectively). Blood samples were taken at 0, 15, 30, 45, 60, and 120 min. For the long-term effect, the second group (10 monkeys) was given a single injection of ketamine (10 mg/kg) once a week for 4 consecutive weeks. Blood samples were taken 5 to 10 min after each injection, then were used to determine the variation in hormone concentrations among the monkeys (inter-individual variation) and within each monkey (intra-individual variation). There were no statistically significant differences in serum cortisol, testosterone, ILH, and BioLH values between the first blood sample (before the ketamine injection) and sequential blood samples in monkeys of the first group. Although intra-individual variation in the hormones (i.e., hormonal change within each monkey) was not statistically significant, inter-individual variation (among the monkeys) was significantly (0.00001 < P < 0.033) different in monkeys of the second group. These results indicate that an adequate number of animals must be used to minimize animal-to-animal variability. Our results confirm that ketamine is a suitable anesthetic agent to immobilize male cynomolgus monkeys in experimental studies (short- and long-term studies) aimed at elucidating hormonal changes.     

Hyperprolactinemia in monkeys: Induction by an estrogen-progesterone synergy

To evaluate the synergistic effect of estrogens and progesterone on prolactin secretion, rhesus and cynomolgus monkeys in the early follicular phase received estradiol benzoate (100 μg/kg/day, sc) alone for 14 days, then in combination with progesterone (subcutaneous silastic capsule) for an additional 14 days. Blood was drawn daily by femoral venipuncture under ketamine hydrochloride anesthesia (15mg/kg). Similarly, this protocol for exogenous steroid treatment was employed in a monkey having a chronically indwelling (femoral insertion into the vena cava) cannula maintained by a vest and mobile tether apparatus; however, no anesthesia was used to obtain serum specimens. In addition, this assembly was applied to six monkeys to determine the acute effects of ketamine hydrochloride on prolactin secretion. Concentrations of prolactin, estradiol-17β, and progesterone in serum were determined by conventional radioimmunoassays. Under estrogen therapy alone, mean circulating prolactin levels declined from ~15 to < 5 ng/ml; in contrast, the addition of progesterone caused an abrupt serum prolactin elevation, ~8–12 fold. This estradiol-progesterone course led to sustained hyperprolactinemia in the chronically catheterized Monkey, whereas ketamine administration raised serum prolactin only briefly, the elevation lasting less than three hours after injection. These findings establish that an estrogen-progesterone synergy, separate from the transient effects of ketamine, Induced hyperprolactinemia in cycling monkeys having prevailing levels of estrogen and progesterone near those characteristic of late gestation, when sustained prolactin elevations are observed normally.     

Comparison of ketmine with the combination of ketamine and xylazine for effective anesthesia in the rhesus monkey (Macaca mulatta).

The addition of xylazine to ketamine hydrochloride was found to enhance analgesia, anesthesia, and muscle relaxation in rhesus monkeys. At 0.10 ml/kg body weight, this combination provided adequate anesthesia for such procedures as cisternal puncture, lumbar spinal puncture, insertion of urinary catheters, finger amputations, and tattooing. The combination of ketamine and xylazine did depress the heart rate, respiration rate, and body temperature more than the administration of ketamine alone. The period of anesthesia also was prolonged, but the monkeys regained consciousness more rapidly at the end of the anesthetic period.     

Respiration rate, heart rate, and body temperature values in cynomolgus monkeys (Macaca fascicularis) during barbiturate anesthesia

Respiration rate, heart rate, and body temperature values were obtained from 14 cynomolgus monkeys (Macaca fascicularis) during neurosurgery under barbiturate anesthesia. Vital sign values markedly declined below baseline during the early stages of surgery, steadily increased as surgery progressed and neared completion, and finally returned to baseline by the end of the postsurgical recovery period. There was considerable variability among the 14 monkeys, but the ranking of each monkey relative to the others remained constant across the period of observation. The findings suggested that the cynomolgus monkey may be more sensitive to barbiturates than the rhesus monkey, and cynomolgus monkeys may exhibit considerable individual differences in their sensitivity to barbiturates.     

印度尼西亚源食蟹猴干扰素-γ基因的克隆和序列分析

目的获得印度尼西亚食蟹猴的干扰素-γ基因,为常用实验猕猴干扰素-γ的基因工程生产奠定基础。方法根据GenBank上公布的恒河猴干扰素-γ基因序列设计特异性引物,从印度尼西亚食蟹猴的外周血液中分离单核淋巴细胞,利用Trizol试剂,提取淋巴细胞的总RNA,通过RT-PCR的方法获得干扰素-γ基因片段,并对该片段进行克隆、鉴定和序列分析。结果扩增到一498bp的目的片段,经序列测定证实为印度尼西亚食蟹猴的干扰素-γ基因,与恒河猴、人及狒狒的干扰素-γ基因相比,同源性分别为100%、96%、99%。结论常用的两种实验猕猴食蟹猴与恒河猴的干扰素-γ基因完全相同。     

山羊单纯与复合全身麻醉效果的比较

目的对比山羊单纯麻醉与复合麻醉的效果,探讨一种安全高效便捷的山羊麻醉方法。方法选取山羊30只,随机分为A、B、C三组,A组给予单纯戊巴比妥钠麻醉,B组给予单纯氯胺酮麻醉,C组给予地西泮、戊巴比妥钠和氯胺酮复合麻醉,记录三种麻醉方法的起效时间、麻醉维持时间、麻醉药物用量及麻醉死亡率。结果地西泮、戊巴比妥钠和氯胺酮复合麻醉,起效快、麻醉维持时间长、动物死亡率低、麻醉效果好。结论安定、戊巴比妥钠和氯胺酮复合麻醉优于单纯麻醉,是一种高效、便捷、安全山羊全身麻醉方法。     

Vital signs monitoring during injectable and inhalant anesthesia in mice

Selecting the appropriate anesthetic protocol for the individual animal is an essential part of laboratory animal experimentation. The present study compared the characteristics of four anesthetic protocols in mice, focusing on the vital signs. Thirty-two male ddY mice were divided into four groups and administered anesthesia as follows: pentobarbital sodium monoanaesthesia; ketamine and xylazine combined (K/X); medetomidine, midazolam, and butorphanol combined (M/M/B); and isoflurane. In each group, rectal temperature, heart rate, respiratory rate, and O₂ saturation (SPO₂) were measured, and the changes over time and instability in these signs were compared. The anesthetic depth was also evaluated in each mouse, and the percentage of mice achieving surgical anesthesia was calculated. K/X anesthesia caused remarkable bradycardia, while the respiratory rate and SPO₂ were higher than with the others, suggesting a relatively strong cardiac influence and less respiratory depression. The M/M/B group showed a relatively lower heart rate and SPO₂, but these abnormalities were rapidly reversed by atipamezole administration. The pentobarbital group showed a lower SPO₂, and 62.5% of mice did not reach a surgical anesthetic depth. The isoflurane group showed a marked decrease in respiratory rate compared with the injectable anesthetic groups. However, it had the most stable SPO₂ among the groups, suggesting a higher tidal volume. The isoflurane group also showed the highest heart rate during anesthesia. In conclusion, the present study showed the cardiorespiratory characteristics of various anesthetic protocols, providing basic information for selecting an appropriate anesthetic for individual animals during experimentation.     

Menstrual cycles in rhesus monkeys (Macaca mulatta) are unaffected by a single dose of the anesthetics ketamine and xylazine administered during the midfollicular phase at laparoscopy

To identify an anesthetic regimen that produces more complete relaxation and analgesia than ketamine hydrochloride (Ketaset®) alone, a combination of ketamine (15 mg/kg body weight) and the hypnotic xylazine (Rompun®, 0.33 mg/kg) was evaluated. Since the desired experimental application required that the anesthetic not interfere with normal hormonal events during the menstrual cycle, this combination administered on day 6 of the cycle was tested to determine whether hormonal surges, incidence of ovulation, or cycle length would be altered relative to the use of ketamine alone. In five of six animals, ketamine plus xylazine had no effect on the occurrence of timely surges of estrogen, luteinizing hormone (LH), or follicle-stimulating hormone (FSH), or on ovulation as determined by the presence of a corpus luteum at laparoscopy and normal serum concentrations of progesterone. There were no significant differences between the cycle during treatment and previous cycles in the same animal for length of the menstrual cycle (26.0 ± 2.3 [5] days; X? ± S.D. [n] or luteal phase (13.4 ± 2.4 [5] days). Likewise, these values did not differ from those of ten control monkeys treated with ketumine only on day 5 or 6 of the cycle (incidence of ovulation, 10/10; cycle length, 27.9 ± 1.8 [10]; luteal phase length, 15.1 ± 1.4 [10], P > 0.05). Patterns of circulating progesterone were not altered by the addition of xylazine anesthesia. These findings indicate that xylazine, given in the midfollicular phase, did not alter ovulatory events or menstrual cycle characteristics in rhesus monkeys. Ketamine plus xylazine apparently provides anesthesia appropriate for laparoscopy.